Kosan Biosciences Incorporated
Kosan Biosciences Incorporated, often referred to as Kosan, is a pioneering biotechnology company headquartered in the United States. Founded in the early 2000s, Kosan has established itself as a leader in the development of innovative therapeutics, particularly in the fields of cancer and infectious diseases.
The company focuses on harnessing the power of its proprietary drug discovery platform, which utilises advanced molecular technologies to create unique small-molecule therapeutics. Kosan's commitment to scientific excellence has led to significant milestones, including successful clinical trials and partnerships with major pharmaceutical firms.
With a strong market position, Kosan continues to make strides in the biotechnology industry, aiming to deliver transformative treatments that address unmet medical needs. Its dedication to research and development sets it apart, making Kosan a notable player in the competitive landscape of biopharmaceuticals.
+38 vs industry average
Kosan Biosciences Incorporated’s score of 76 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Kosan Biosciences Incorporated?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Kosan Biosciences Incorporated yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Kosan Biosciences Incorporated’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Kosan Biosciences Incorporated yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Bristol-Myers Squibb Company
Carbon Disclosure Project
Inherited from Bristol-Myers Squibb CompanyThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Bristol-Myers Squibb CompanyRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project